Verified Nov 2026
Other
·
Saint Paul, Minnesota
·
Since 1977
MGC Diagnostics is a medical technology company headquartered in Saint Paul, Minnesota, founded in 1977 and listed publicly under the ticker MGCD. It employs roughly 500 to 1,000 people and reports revenue in the range of about $60 million. The company makes non-invasive diagnostic systems for cardiorespiratory disease, including pulmonary function testing and cardiopulmonary exercise systems, and serves healthcare providers, pharmaceutical companies, and clinical research organizations. In 2026 it began direct commercial operations in Canada and completed EU registration and CE marking for its Fenom Flo system.
MGC Diagnostics at a glance
Revenue
60M
Employees
500-1,000
Founded
1977
Headquarters
Saint Paul, Minnesota
Ownership
Publicly traded (NASDAQ: MGCD)
Import activity
12
Industries
Automotive
Electric Vehicles
Medical
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
12
Named foreign suppliers
4
Top origins
Taiwan · Italy · Belgium · Germany
Shared foreign counterparties do not establish that these companies buy from MGC Diagnostics.
What this tells a buyer
No customs data is available for the company, and its most recent reported development is the August 2026 completion of EU registration and CE marking for the Fenom Flo system.
The company's product lines include spirometers, body plethysmographs, metabolic stress testing systems, and gas exchange analysis systems, along with associated consumables and support contracts.
MGC Diagnostics has operated for more than 40 years and, according to its company description, sells in more than 45 countries.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
Overview
MGC Diagnostics is a medical technology company headquartered in Saint Paul, Minnesota, founded in 1977 and listed publicly under the ticker MGCD. It employs roughly 500 to 1,000 people and reports revenue in the range of about $60 million. The company makes non-invasive diagnostic systems for cardiorespiratory disease, including pulmonary function testing and cardiopulmonary exercise systems, and serves healthcare providers, pharmaceutical companies, and clinical research organizations. In 2026 it began direct commercial operations in Canada and completed EU registration and CE marking for its Fenom Flo system.
At a glance
Attribute | Detail |
|---|---|
Founded | 1977 |
Headquarters | Saint Paul, Minnesota |
Employees | 500-1,000 |
Revenue | 60M |
Ownership | Publicly traded (NASDAQ: MGCD) |
What MGC Diagnostics makes
The company's product lines include spirometers, body plethysmographs, metabolic stress testing systems, and gas exchange analysis systems, along with associated consumables and support contracts.
Trade and customs footprint
No customs data is available for the company, and its most recent reported development is the August 2026 completion of EU registration and CE marking for the Fenom Flo system. US customs bill-of-lading records list 12 inbound shipments across 4 foreign suppliers, with top origins including Taiwan · Italy · Belgium · Germany.
Latest developments
2026-10-14 — Notice of Intent to Sole Source - MGC… | CLEATUS (cleat.ai)
2026-10-01 — MGC Diagnostics Corporation (via Public) / MGC Diagnostics Expands Direct Commercial Operations Across Canada (publicnow.com)
2026-10-01 — Canadian healthcare providers now work directly with MGC Diagnostics! | MGC Diagnostics (linkedin.com)
2026-08-25 — MGC Diagnostics Corporation (via Public) / MGC Diagnostics Completes EU Registration and CE Marking for Fenom Flo™ (publicnow.com)
2026-05-06 — Important Update: MGC Diagnostics Transitions to Direct Sales in Canada – Novus Medical (novusmedical.ca)
2026-02-26 — MGC Diagnostics Expands Portfolio With Fenom Flo™ U.S. Launch - MGC Diagnostics (mgcdiagnostics.com)
Facilities
MGC Diagnostics is headquartered in Saint Paul, Minnesota. Public sources also reference these locations:
Saint Paul, Minnesota — sourceready.com
Company details
MGC Diagnostics has operated for more than 40 years and, according to its company description, sells in more than 45 countries. MGC Diagnostics was founded in 1977, has an estimated 500-1,000 employees, and is headquartered in Saint Paul, Minnesota.
Frequently asked questions
What does MGC Diagnostics do?
MGC Diagnostics is a medical technology company headquartered in Saint Paul, Minnesota, founded in 1977 and listed publicly under the ticker MGCD. It employs roughly 500 to 1,000 people and reports revenue in the range of about $60 million. The company makes non-invasive diagnostic systems for cardiorespiratory disease, including pulmonary function testing and cardiopulmonary exercise systems, and serves healthcare providers, pharmaceutical companies, and clinical research organizations. In 2026 it began direct commercial operations in Canada and completed EU registration and CE marking for its Fenom Flo system.
Where is MGC Diagnostics headquartered?
MGC Diagnostics is headquartered in Saint Paul, Minnesota (350 Oak Grove Pkwy, Saint Paul, Minnesota, 55127-8507).
When was MGC Diagnostics founded?
MGC Diagnostics was founded in 1977.
How big is MGC Diagnostics?
MGC Diagnostics has an estimated 500-1,000 employees, with revenue in the 60M range.
Is MGC Diagnostics publicly traded?
Publicly traded (NASDAQ: MGCD). Public financial figures are drawn from its filings.
Does MGC Diagnostics import from overseas suppliers?
US customs bill-of-lading records show 12 inbound shipments for MGC Diagnostics, with top origins including Taiwan · Italy · Belgium · Germany.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.